Pinnacle Bancorp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.19M | Buy |
12,680
+835
| +7% | +$180K | 0.83% | 30 |
|
|
2026
Q1 | $2.58M | Sell |
11,845
-71
| -0.6% | -$15.7K | 0.76% | 30 |
|
|
2025
Q4 | $2.72M | Sell |
11,916
-35
| -0.3% | -$7.97K | 0.8% | 28 |
|
|
2025
Q3 | $2.77M | Sell |
11,951
-167
| -1% | -$34K | 0.82% | 27 |
|
|
2025
Q2 | $2.25M | Sell |
12,118
-356
| -3% | -$66.2K | 0.69% | 32 |
|
|
2025
Q1 | $2.61M | Sell |
12,474
-507
| -4% | -$98.6K | 0.85% | 27 |
|
|
2024
Q4 | $2.31M | Sell |
12,981
-115
| -0.9% | -$21.1K | 0.75% | 28 |
|
|
2024
Q3 | $2.59M | Sell |
13,096
-68
| -0.5% | -$12.7K | 0.69% | 27 |
|
|
2024
Q2 | $2.26M | Sell |
13,164
-708
| -5% | -$117K | 0.67% | 26 |
|
|
2024
Q1 | $2.53M | Hold |
13,872
| – | – | 0.75% | 24 |
|
|
2023
Q4 | $2.15M | Sell |
13,872
-480
| -3% | -$70K | 0.7% | 25 |
|
|
2023
Q3 | $2.14M | Sell |
14,352
-30
| -0.2% | -$4.4K | 0.76% | 25 |
|
|
2023
Q2 | $1.94M | Buy |
14,382
+462
| +3% | +$67.7K | 0.66% | 27 |
|
|
2023
Q1 | $2.22M | Buy |
13,920
+234
| +2% | +$35.8K | 0.81% | 26 |
|
|
2022
Q4 | $2.21M | Sell |
13,686
-853
| -6% | -$131K | 0.85% | 21 |
|
|
2022
Q3 | $1.95M | Buy |
14,539
+161
| +1% | +$23.1K | 0.84% | 23 |
|
|
2022
Q2 | $2.2M | Sell |
14,378
-656
| -4% | -$100K | 0.91% | 21 |
|
|
2022
Q1 | $2.44M | Buy |
15,034
+364
| +2% | +$52.9K | 0.85% | 23 |
|
|
2021
Q4 | $1.99M | Buy |
14,670
+92
| +0.6% | +$10.9K | 0.7% | 29 |
|
|
2021
Q3 | $1.57M | Buy |
14,578
+869
| +6% | +$99.3K | 0.63% | 31 |
|
|
2021
Q2 | $1.54M | Buy |
13,709
+90
| +0.7% | +$10.1K | 0.7% | 22 |
|
|
2021
Q1 | $1.47M | Buy |
13,619
+203
| +2% | +$21.7K | 0.71% | 22 |
|
|
2020
Q4 | $1.44M | Sell |
13,416
-210
| -2% | -$20.2K | 0.89% | 22 |
|
|
2020
Q3 | $1.19M | Sell |
13,626
-63
| -0.5% | -$5.93K | 0.84% | 25 |
|
|
2020
Q2 | $1.34M | Hold |
13,689
| – | – | 1% | 20 |
|
|
2020
Q1 | $1.04M | Buy |
13,689
+750
| +6% | +$63.9K | 0.89% | 22 |
|
|
2019
Q4 | $1.15M | Buy |
12,939
+92
| +0.7% | +$7.64K | 0.79% | 28 |
|
|
2019
Q3 | $973K | Buy |
12,847
+200
| +2% | +$13.7K | 0.56% | 34 |
|
|
2019
Q2 | $920K | Buy |
12,647
+63
| +0.5% | +$4.95K | 0.52% | 37 |
|
|
2019
Q1 | $1.01M | Sell |
12,584
-265
| -2% | -$21.7K | 0.59% | 33 |
|
|
2018
Q4 | $1.19M | Buy |
+12,849
| New | +$1.13M | 0.73% | 21 |
|
|
2017
Q1 | $919K | Buy |
+14,097
| New | +$886K | 0.65% | 25 |
|
Other funds holding ABBV
Pinnacle Bancorp's ABBV Position: Q2 2026 in Review
Pinnacle Bancorp increased its AbbVie (ABBV) stake by 7% in Q2 2026, buying an estimated $180K and bringing the position to 12,680 shares worth $3.19M. The position accounts for 0.83% of the portfolio, ranked #30.
Pinnacle Bancorp first reported a position in ABBV in Q1 2017 and has held it in 32 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Pinnacle Bancorp held 12,680 shares of AbbVie worth $3.19M as of Q2 2026.
- Pinnacle Bancorp bought 835 AbbVie shares in Q2 2026, an estimated $180K.
- AbbVie made up 0.83% of Pinnacle Bancorp's portfolio in Q2 2026, its #30 holding.
- Pinnacle Bancorp first reported a position in AbbVie in Q1 2017 and has held it in 32 quarters since.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.